Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study

Alexander Rombauts; Carmen Infante; Mikel Del Álamo Martínez de Lagos; Jorge Alba; Adoración Valiente; Carla Donado-Mazarrón; Marta Carretero-Ledesma; Regino Rodríguez-Álvarez; Sonia Omatos; Zaira R Palacios-Baena; Gabriela Abelenda-Alonso; María Del Mar Silva-Sánchez; Ane Josune Goikoetxea-Agirre; José A Oteo; Jesús Rodríguez-Baño; Elisa Cordero; Carlota Gudiol; Javier Sánchez-Céspedes; Jordi Carratalà

doi:10.1016/j.jinf.2022.11.009

Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study

J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.11.009. Epub 2022 Nov 17.

Authors

Alexander Rombauts¹, Carmen Infante², Mikel Del Álamo Martínez de Lagos³, Jorge Alba⁴, Adoración Valiente⁵, Carla Donado-Mazarrón¹, Marta Carretero-Ledesma⁶, Regino Rodríguez-Álvarez³, Sonia Omatos⁴, Zaira R Palacios-Baena⁵, Gabriela Abelenda-Alonso¹, María Del Mar Silva-Sánchez⁶, Ane Josune Goikoetxea-Agirre³, José A Oteo⁴, Jesús Rodríguez-Baño⁷, Elisa Cordero⁸, Carlota Gudiol⁹, Javier Sánchez-Céspedes¹⁰, Jordi Carratalà⁹

Affiliations

¹ Department of Infectious Diseases, Hospital Universitari de Bellvitge - Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet de Llobregat, Barcelona, Spain.
² Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
³ Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain.
⁴ Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain.
⁵ Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.
⁶ Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
⁷ Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain; Department of Medicine, School of Medicine, University of Seville, Seville, Spain.
⁸ Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Department of Medicine, School of Medicine, University of Seville, Seville, Spain.
⁹ Department of Infectious Diseases, Hospital Universitari de Bellvitge - Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Universitat de Barcelona, Barcelona, Spain.
¹⁰ Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jsanchez-ibis@us.es.

No abstract available

Keywords: COVID-19; Long-COVID; Risk factors; SARS-CoV-2 RNAemia; Viral load.

Publication types

Observational Study
Multicenter Study
Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Cohort Studies
Humans
Post-Acute COVID-19 Syndrome
RNA, Viral / genetics
Risk Factors
SARS-CoV-2*

Substances

RNA, Viral